Products iDose TR (Travoprost intracameral Implant) 75mcg
iDose TR (Travoprost intracameral Implant) 75mcg Approved Recruiting 🔥 Hot Open Angle Glaucoma, Pigmentary Glaucoma, Pseudoexfoliation Glaucoma
Jan 5, 2026 → Dec 31, 2031
About iDose TR (Travoprost intracameral Implant) 75mcg iDose TR (Travoprost intracameral Implant) 75mcg is a approved stage product being developed by Glaukos for Open Angle Glaucoma. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07228221. Target conditions include Open Angle Glaucoma, Pigmentary Glaucoma, Pseudoexfoliation Glaucoma.
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT07228221 Approved Recruiting Jan 5, 2026 Dec 31, 2031 Open Angle Glaucoma
Product Company Stage Hype Score Ilofotase alfa + Placebo AM-Pharma Phase 2 Test - Bimatoprost 0.01% Ophthalmic Solution + Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution) Mankind Pharma Phase 3 Latanoprost plus adjunctive glaucoma medication Sight Sciences Approved Pirtobrutinib + Placebo Eli Lilly Phase 1/2 Anti-(integrin beta-3) human monoclonal antibody Rallybio Phase 2 SBI-100 Ophthalmic Emulsion, 0.5% + SBI-100 Ophthalmic Emulsion, 1.0% + SBI-100 Ophthalmic Emulsion, Placebo Skye Bioscience Phase 2 Micafungin Astellas Pharma Approved SDP-133 + Lumigan Sun Pharmaceutical Phase 3 Brinzolamide ophthalmic suspension + Azopt® Sun Pharmaceutical Phase 3 Placebo + Lusutrombopag Shionogi Phase 2 Lusutrombopag Shionogi Phase 2 Avatrombopag + Avatrombopag + Placebo Eisai Phase 2 E5501 Eisai Phase 1 avatrombopag Eisai Phase 1 E5501 + Drug: E5501 Eisai Phase 1 E5501 40 mg 2 x 20-mg tablets, orally, fasted + E5501 40 mg 2 x 20-mg tablets, orally, with food + E5501 40mg 2 x 20-mg tablets, orally, fasted + E5501 40 mg 2 x 20-mg tablets, orally, with food Eisai Phase 1 Eltrombopag + Avatrombopag + Standard of care Eisai Phase 3 Placebo + Avatrombopag tablets Eisai Phase 2 avatrombopag (lower baseline platelet count) + placebo (lower baseline platelet count) + avatrombopag (higher baseline platelet count) + placebo (higher baseline platelet count) Eisai Phase 3 avatrombopag + Placebo Eisai Phase 2
Other Products from Glaukos